| (210) | Number of the EPO application | 21756070 |
| (220) | Filing date of the EPO application | 2021.08.14 |
| (80) | EPO patent specification publication (B) | EPB nr. 04/2023, 2023.01.25 |
| (110) | EPO patent number | 4010082 |
| (21) | Number of the application | e 2022 0681 |
| (71) | Name(s) of applicant(s), code of the country | GammaDelta Therapeutics Limited, GB; |
| (72) | Name(s) of inventor(s), code of the country | UDEN Mark, GB;
TUNA Mihriban, GB;
MOUNT Natalie, GB;
GOOD Robert, GB;
FREEDMAN Joshua, GB;
BHUMBRA Shefali, GB;
NUSSBAUMER Oliver, GB;
MEHTA Raj Jaysukhlal, GB; |
| (73) | Name(s) of owner(s), code of the country | GammaDelta Therapeutics Limited, GB; |
| (54) | Title of the invention | MULTISPECIFIC ANTI-TCR DELTA VARIABLE 1 ANTIBODIES |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61P 35/00 (2006.01.01); A61K 35/17 (2015.01.01); C07K 16/28 (2006.01.01); C12N 5/0783 (2010.01.01); C07K 16/30 (2006.01.01); C07K 16/32 (2006.01.01); C07K 16/40 (2006.01.01); C07K 16/42 (2006.01.01) |
| (19) | Country | GB |
| (41) | Date of publication of the application | 2022.07.31 |
| (30) | Priority | PCT/GB2020/0519, 2020.08.14, WO; 202102222, 2021.02.17, GB; 202102224, 2021.02.17, GB |
| (86) | International application | PCT/IB2021/057509, 2021.08.14 |
| (87) | International publication | WO 2022/034562, 2022.02.17 |